Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Misako Fukumoto
Indoleamine 2,3-Dioxygenase as a Prognostic Factor in Patients With Non-Small Cell Lung Cancer
Journal of Clinical & Cellular Immunology
Related publications
MA11.05 Indoleamine 2,3-Dioxygenase Expression in Non-Small-Cell Lung Cancer: Analyses of Prevalence, Clinical Correlations and Prognostic Impact
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.01-10 Dyspnea as a Prognostic Factor in Hispanic Patients With Non-Small Cell Lung Cancer Cohort
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Human Immunodeficiency Virus Infection as a Prognostic Factor in Surgical Patients With Non-Small Cell Lung Cancer
Annals of Thoracic Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Circulating Tumor Cells as a Prognostic Factor in Patients With Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
The Hemoglobin Level as a Prognostic Factor in Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Cis-Platinum
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Prognostic Significance of Pigment Epithelium-Derived Factor Expression in Patients With Non-Small-Cell-Lung Cancer
Advances in Lung Cancer
Indoleamine 2,3-Dioxygenase 1 (IDO1)
Science-Business eXchange
Sex as an Independent Prognostic Factor in a Population-Based, Non-Small Cell Lung Cancer Cohort
Canadian Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine